Tarriff Scott
Insider CIK 1469124 · ZIOP Director · EGRX President and CEO, Director, 10% owner · SYN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2024-02-28 | 2024-03-01 | 2,119 | $6.27 | $13.3K | 460,621 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2024-02-27 | 2024-02-29 | 3,154 | $6.44 | $20.3K | 462,740 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award | 2024-02-27 | 2024-02-29 | 12,950 | — | $0 | 465,894 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2024-01-05 | 2024-01-09 | 4,322 | $5.13 | $22.2K | 541,125 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-11-02 | 2023-11-03 | 10,694 | $13.87 | $148.3K | 545,447 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-11-01 | 2023-11-03 | 10,925 | $13.82 | $151.0K | 556,141 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-10-03 | 2023-10-04 | 10,024 | $14.41 | $144.4K | 567,776 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-10-03 | 2023-10-04 | 710 | $15.11 | $10.7K | 567,066 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-10-02 | 2023-10-04 | 9,511 | $15.23 | $144.9K | 577,800 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-05-16 | 2023-05-18 | 15,000 | $19.98 | $299.7K | 587,311 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-05-15 | 2023-05-15 | 14,800 | $21.06 | $311.7K | 1,595,134 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-05-15 | 2023-05-15 | 200 | $21.52 | $4.3K | 1,594,934 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-05-12 | 2023-05-15 | 3,131 | $19.69 | $61.6K | 1,621,803 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-05-12 | 2023-05-15 | 11,869 | $20.42 | $242.4K | 1,609,934 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2023-05-11 | 2023-05-15 | 15,000 | $20.71 | $310.6K | 1,624,934 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award | 2023-03-01 | 2023-03-02 | 70,900 | — | $0 | 1,639,934 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2023-02-28 | 2023-03-02 | 3,113 | $28.00 | $87.2K | 1,569,034 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2023-01-23 | 2023-01-24 | 3,732 | $33.64 | $125.5K | 1,572,147 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2023-01-05 | 2023-01-09 | 3,827 | $29.26 | $112.0K | 1,575,879 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award | 2022-02-28 | 2022-03-02 | 34,800 | — | $0 | 1,579,706 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | M Exercise deriv | 2021-04-01 | 2021-04-05 | 31,201 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | M Exercise | 2021-04-01 | 2021-04-05 | 31,201 | $8.78 | $273.9K | 1,561,184 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2021-04-01 | 2021-04-05 | 16,278 | $41.87 | $681.6K | 1,544,906 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | G Gift | 2021-02-23 | 2021-04-05 | 16,340 | — | $0 | 1,529,983 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2021-01-23 | 2021-01-26 | 4,631 | $47.70 | $220.9K | 1,546,323 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2020-01-23 | 2020-01-27 | 7,548 | $57.98 | $437.6K | 1,550,954 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2020-01-05 | 2020-01-07 | 145,700 | — | $0 | 145,700 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award | 2020-01-05 | 2020-01-07 | 58,300 | — | $0 | 1,558,502 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2019-12-31 | 2020-01-03 | 50,562 | — | $0 | 50,562 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2019-12-04 | 2019-12-06 | 250,000 | — | $0 | 250,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2019-04-01 | 2019-04-03 | 24,975 | $50.15 | $1.25M | 1,500,202 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2019-03-01 | 2019-03-04 | 12,428 | $51.81 | $643.9K | 1,525,177 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2019-03-01 | 2019-03-04 | 12,000 | $50.51 | $606.1K | 1,537,605 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2019-02-01 | 2019-02-04 | 29,185 | $41.52 | $1.21M | 1,550,505 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2019-02-01 | 2019-02-04 | 900 | $42.30 | $38.1K | 1,549,605 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2019-01-23 | 2019-01-25 | 137,200 | — | $0 | 137,200 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award | 2019-01-23 | 2019-01-25 | 61,300 | — | $0 | 1,579,690 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2019-01-03 | 2019-01-04 | 10,597 | $39.04 | $413.7K | 1,524,362 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2019-01-03 | 2019-01-04 | 5,670 | $39.70 | $225.1K | 1,518,692 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2019-01-03 | 2019-01-04 | 302 | $40.57 | $12.3K | 1,518,390 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2019-01-02 | 2019-01-04 | 6,500 | $39.30 | $255.4K | 1,543,459 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2019-01-02 | 2019-01-04 | 8,500 | $40.03 | $340.3K | 1,534,959 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2018-12-31 | 2019-01-02 | 126,700 | — | $0 | 126,700 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2018-12-06 | 2018-12-07 | 79,500 | — | $0 | 79,500 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | M Exercise deriv | 2018-06-28 | 2018-07-03 | 124,804 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | M Exercise | 2018-06-28 | 2018-07-03 | 124,804 | $4.04 | $504.2K | 1,549,959 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | M Exercise deriv | 2018-03-30 | 2018-04-03 | 113,104 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | M Exercise | 2018-03-30 | 2018-04-03 | 113,104 | $4.04 | $456.9K | 1,483,050 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | F Tax w/h | 2018-03-30 | 2018-04-03 | 57,895 | $52.69 | $3.05M | 1,425,155 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2018-01-07 | 2018-01-09 | 189,000 | — | $0 | 189,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2018-01-07 | 2018-01-09 | 157,000 | — | $0 | 157,000 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2017-12-29 | 2018-01-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2017-12-20 | 2017-12-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2017-01-04 | 2017-01-06 | 200,900 | — | $0 | 200,900 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2016-12-30 | 2017-01-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2016-11-30 | 2016-12-02 | 168,750 | — | $0 | 168,750 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2016-11-18 | 2016-11-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2016-11-18 | 2016-11-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award | 2016-11-18 | 2016-11-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-04-01 | 2016-04-05 | 30,765 | $40.63 | $1.25M | 1,369,946 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-03-01 | 2016-03-03 | 7,802 | $62.70 | $489.2K | 1,412,689 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-03-01 | 2016-03-03 | 11,978 | $63.52 | $760.8K | 1,400,711 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-02-01 | 2016-02-02 | 5,367 | $66.03 | $354.4K | 1,433,484 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-02-01 | 2016-02-02 | 3,600 | $67.46 | $242.9K | 1,429,884 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-02-01 | 2016-02-02 | 5,260 | $68.52 | $360.4K | 1,424,624 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-02-01 | 2016-02-02 | 2,431 | $69.95 | $170.0K | 1,422,193 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-02-01 | 2016-02-02 | 1,702 | $71.84 | $122.3K | 1,420,491 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2016-01-04 | 2016-01-05 | 180,000 | — | $0 | 180,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-01-04 | 2016-01-05 | 11,776 | $85.65 | $1.01M | 1,441,624 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2016-01-04 | 2016-01-05 | 2,773 | $87.02 | $241.3K | 1,438,851 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2015-12-31 | 2016-01-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2015-12-04 | 2015-12-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-12-01 | 2015-12-02 | 1,300 | $91.46 | $118.9K | 1,453,400 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-12-01 | 2015-12-02 | 2,806 | $86.92 | $243.9K | 1,464,644 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-12-01 | 2015-12-02 | 3,700 | $90.99 | $336.7K | 1,454,700 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-12-01 | 2015-12-02 | 1,500 | $88.80 | $133.2K | 1,458,400 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-12-01 | 2015-12-02 | 4,744 | $87.85 | $416.8K | 1,459,900 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-11-02 | 2015-11-03 | 11,713 | $64.07 | $750.5K | 1,475,076 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-11-02 | 2015-11-03 | 7,626 | $65.50 | $499.5K | 1,467,450 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-10-01 | 2015-10-05 | 7,027 | $70.28 | $493.9K | 1,496,089 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-10-01 | 2015-10-05 | 8,235 | $69.27 | $570.4K | 1,487,854 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-10-01 | 2015-10-05 | 1,065 | $68.50 | $73.0K | 1,486,789 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-10-01 | 2015-10-05 | 1,548 | $72.67 | $112.5K | 1,503,116 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-10-01 | 2015-10-05 | 3 | $74.36 | $223 | 1,504,664 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award | 2015-09-25 | 2015-09-29 | 4,186 | — | $0 | 4,186 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-09-01 | 2015-09-03 | 1,878 | $76.09 | $142.9K | 1,504,716 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-09-01 | 2015-09-03 | 2,526 | $77.93 | $196.9K | 1,518,386 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-09-01 | 2015-09-03 | 11,792 | $76.88 | $906.6K | 1,506,594 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-09-01 | 2015-09-03 | 49 | $75.12 | $3.7K | 1,504,667 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-08-03 | 2015-08-04 | 2,342 | $95.39 | $223.4K | 1,520,912 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-08-03 | 2015-08-04 | 10,658 | $96.36 | $1.03M | 1,523,254 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-07-01 | 2015-07-02 | 1,483 | $80.28 | $119.1K | 1,543,637 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-07-01 | 2015-07-02 | 4,502 | $81.50 | $366.9K | 1,545,120 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-07-01 | 2015-07-02 | 6,015 | $78.98 | $475.1K | 1,537,622 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-07-01 | 2015-07-02 | 3,710 | $77.58 | $287.8K | 1,533,912 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | S Sale | 2015-03-20 | 2015-07-02 | 120,000 | $42.00 | $5.04M | 1,549,622 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2015-03-13 | 2015-03-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | A Award deriv | 2014-08-26 | 2014-08-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2014-04-17 | 2014-04-21 | 105,000 | — | $0 | 105,000 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion deriv | 2014-02-18 | 2014-02-20 | 171,109 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | X Exercise deriv | 2014-02-18 | 2014-02-20 | 3,438 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion deriv | 2014-02-18 | 2014-02-20 | 25,376 | — | $0 | 0 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion | 2014-02-18 | 2014-02-20 | 25,376 | — | $0 | 1,668,859 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | X Exercise | 2014-02-18 | 2014-02-20 | 763 | — | $0 | 1,669,622 | SEC↗ |
| EGRX EAGLE PHARMACEUTICALS, INC | C Conversion | 2014-02-18 | 2014-02-20 | 171,109 | — | $0 | 1,643,483 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2013-10-22 | 2013-10-24 | 25,000 | — | $0 | 75,000 | SEC↗ |
| SYN Synthetic Biologics, Inc. | A Award deriv | 2013-03-05 | 2013-03-06 | 25,000 | $1.74 | $43.5K | 50,000 | SEC↗ |